HeartSciences Inc. HSCS
Nasdaq · XNAS · stock · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Chart by TradingView
1/9
Piotroski F — financial health
-74.39
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $4,350 | -$8.8M | $2,470 | -$7.4M | $205,171 |
| 2024 | $18,600 | -$6.6M | $12,519 | -$6.1M | $7.3M |
| 2023 | $5,150 | -$6.4M | $2,354 | -$5.8M | $230,557 |
| 2022 | $14,373 | -$4.8M | $6,483 | -$3.6M | -$6.1M |
Recent insider activity (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Simpson Andrew | See Remarks | 2026-06-22 | Grant | 425,000 | — |
| Simpson Andrew | See Remarks | 2025-11-28 | Grant | 70,000 | — |
| HILZ MARK T | COO, Secretary and Director | 2025-07-29 | Sell | 4,416 | $3.54 |
Why these scores methodology →
Piotroski F-score: 1/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -74.39 (distress)
- Working capital / assets -0.363
- Retained earnings / assets -18.027
- EBIT / assets -1.978
- Equity / liabilities 0.051
Source: SEC EDGAR filings · CIK 0001468492 · as of 2025-04-30. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.